New Antibody Halts Aggressive Prostate Cancer | Science News

A breakthrough antibody drug, fully human and designed to stop aggressive prostate cancer from spreading, shows strong promise in preclinical trials. Targeting metastasis—the deadly spread to bones and lymph nodes—this treatment could offer fewer side effects than current options. While researchers are optimistic, major hurdles remain, including safety studies and FDA approval. The team, backed by years of collaboration across institutions and cancer-focused funding, plans to test the antibody’s potential against other solid tumors, aiming to boost survival and quality of life for advanced prostate cancer patients. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6bd6e792ff108b83